drugset / Trial / NCT00003021

Bizelesin in Treating Patients With Advanced Cancer

NCT00003021 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of bizelesin in treating patients who have advanced cancer.

Timeline

Start
1997-08
Primary completion
2002-11
Completion
2002-11

Drugs

EvaluationDrugModalityDoseRoute
Subject bizelesin Small molecule — Intravenous